Overview

Safety, Tolerability and Efficacy of DEXDOR in Pediatric Patients in ICU

Status:
Completed
Trial end date:
2018-05-21
Target enrollment:
Participant gender:
Summary
Open clinical trial to evaluate safety, tolerability, and efficacy of Dexdor for sedation in paediatric patients in intensive care settings. Multi-centre trial in Russia for marketing registration of Dexdor
Phase:
Phase 4
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Dexmedetomidine